Huadong Medicine released its semi-annual report for 2026, achieving operating revenue of 22.067 billion yuan, up 1.81% year on year; net profit attributable to shareholders of the listed company was 1.861 billion yuan, up 2.53% year on year. The company plans to distribute a cash dividend of 3.5 yuan per 10 shares, tax included. According to the financial report, the company's net profit for the second quarter was 859 million yuan, compared with 1.002 billion yuan in the first quarter, a quarter-on-quarter decline of 14%.
Huadong Medicine Co LtdNet profit up 2.53% YoY and cash dividend announced
